Related references
Note: Only part of the references are listed.The novel long noncoding RNA CRART16 confers cetuximab resistance in colorectal cancer cells by enhancing ERBB3 expression via miR-371a-5p
Xiaoqian Zhang et al.
CANCER CELL INTERNATIONAL (2020)
Emerging molecular functions of microRNA-124: Cancer pathology and therapeutic implications
Maryam Moghadasi et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer
Ofra Novoplansky et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Is EGFR really a therapeutic target in head and neck cancers?
Vijay Agarwal et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis
Ming-Jiu Chen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma
Bo Zeng et al.
BMC CANCER (2019)
Interfering cellular lactate homeostasis overcomes Taxol resistance of breast cancer cells through the microRNA-124-mediated lactate transporter (MCT1) inhibition
Lu Hou et al.
CANCER CELL INTERNATIONAL (2019)
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Elham Alsahafi et al.
CELL DEATH & DISEASE (2019)
PVT1 Signaling Is a Mediator of Cancer Progression
Camille Derderian et al.
FRONTIERS IN ONCOLOGY (2019)
MicroRNA-124: An emerging therapeutic target in cancer
Xinqi Jia et al.
CANCER MEDICINE (2019)
Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus
Olorunseun O. Ogunwobi et al.
FRONTIERS IN ONCOLOGY (2019)
EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma
Yingqin Li et al.
CELL DEATH AND DIFFERENTIATION (2019)
Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p
Xiling Zheng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC
Chao Liu et al.
EBIOMEDICINE (2019)
DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A
Yang Hu et al.
CLINICAL EPIGENETICS (2019)
Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma
Haiquan Lu et al.
JCI INSIGHT (2019)
Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling
Wen-Jian Hu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
Changyun Yu et al.
JOURNAL OF CANCER (2018)
LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells
Ching-Ju Shen et al.
JOURNAL OF DRUG TARGETING (2017)
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma
Daniel S. W. Tan et al.
NATURE MEDICINE (2017)
A simple toolset to identify endogenous post-translational modifications for a target protein: a snapshot of the EGFR signaling pathway
Henrick Horita et al.
BIOSCIENCE REPORTS (2017)
Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression
Kazuhiro Yoshida et al.
CARCINOGENESIS (2017)
Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma
Mansi A. Parasramka et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
Paolo Bossi et al.
ONCOTARGET (2016)
miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma
Manchao Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Clinical update on cancer: molecular oncology of head and neck cancer
Y. Suh et al.
CELL DEATH & DISEASE (2014)
Epigenetic regulation of miR-124 by Hepatitis C Virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3
Bing Zeng et al.
FEBS LETTERS (2012)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
R. Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
Jan B. Vermorken et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
